Search Results 7661-7670 of 33588 for oral

  1. A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility - Mayo Clinic

    recombinant human growth hormone [rhGH] insulin, oral beta adrenergic agonists, megestrol acetate, dronabinol, metformin or other drugs) which might ...

  2. Pulmonary Medicine - Doctors - Mayo Clinic

    Olson, M.D., M.S.. Rochester, MN. Areas of focus: Facial fracture repair, Rhinoplasty, Oral surgery, Face lift, Glossectomy, Nasal valve repair, Tonsillectomy ...

  3. Jaw tumors and cysts - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  4. Curriculum - Otolaryngology - Head and Neck Surgery Residency (Minnesota) - Mayo Clinic College of Medicine & Science

    Our five off-service rotations during the intern year include the surgical ICU, emergency department, endocrine surgery, oral maxillofacial surgery, and ...

  5. Publications - Patrick W. McGarrah, M.D. - Mayo Clinic

    Oral Oncology Reports. 2025; 13:100695; Smith KER, Acosta-Medina AA, Dasari S, Ranatunga W, Rech KL, Ravindran A, Young JR, McGarrah PW, Ruan GJ, Zanwar SS ...

  6. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

  7. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

    Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

  8. A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis - Mayo Clinic

    Criterion not applicable for participants on therapy with direct-acting oral anticoagulants (DOACs). Note: Other protocol defined Inclusion/Exclusion ...

  9. Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy Or Plus Camizestrant In HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, Or PALB2m Advanced Breast Cancer - Mayo Clinic

    Disease progression ≤ 1 year (365 days) from the last dose of an oral SERD including camizestrant. Note: Other protocol defined Inclusion/Exclusion ...

  10. Neurology - Doctors - Mayo Clinic

    oral lobe seizure, Seizure , Absence seizure, Febrile seizure. Show more areas of focus for Anthony L. Fine, M.D.. Sanford M. Fineman ...